These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 31651571)

  • 41. Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study.
    Xu C; Yu C; Ma H; Xu L; Miao M; Li Y
    Am J Gastroenterol; 2013 Aug; 108(8):1299-304. PubMed ID: 23567356
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Prevalence of nonalcoholic fatty liver disease and metabolic abnormalities in 387 obese children and adolescents in Beijing, China].
    Zhou X; Hou DQ; Duan JL; Sun Y; Cheng H; Zhao XY; Liu JT; Yang P; Shan XY; Mi J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2013 May; 34(5):446-50. PubMed ID: 24016432
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Promotional effect of nonalcoholic fatty liver disease on Gallstone disease: A systematic review and meta-analysis.
    Shen SS; Gong JJ; Wang XW; Chen L; Qin S; Huang LF; Chen YQ; Ren H; Yang QB; Hu HD
    Turk J Gastroenterol; 2017 Jan; 28(1):31-39. PubMed ID: 27991855
    [TBL] [Abstract][Full Text] [Related]  

  • 44. High Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes Mellitus and Normal Plasma Aminotransferase Levels.
    Portillo-Sanchez P; Bril F; Maximos M; Lomonaco R; Biernacki D; Orsak B; Subbarayan S; Webb A; Hecht J; Cusi K
    J Clin Endocrinol Metab; 2015 Jun; 100(6):2231-8. PubMed ID: 25885947
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Nonalcoholic fatty liver disease in lean individuals in the United States.
    Younossi ZM; Stepanova M; Negro F; Hallaji S; Younossi Y; Lam B; Srishord M
    Medicine (Baltimore); 2012 Nov; 91(6):319-327. PubMed ID: 23117851
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Lean NAFLD: an underrecognized and challenging disorder in medicine.
    Maier S; Wieland A; Cree-Green M; Nadeau K; Sullivan S; Lanaspa MA; Johnson RJ; Jensen T
    Rev Endocr Metab Disord; 2021 Jun; 22(2):351-366. PubMed ID: 33389543
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Characterization of lean patients with nonalcoholic fatty liver disease: potential role of high hemoglobin levels.
    Akyuz U; Yesil A; Yilmaz Y
    Scand J Gastroenterol; 2015 Mar; 50(3):341-6. PubMed ID: 25540973
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Prevalence of Nonalcoholic Fatty Liver Disease (NAFLD) in Patients With Type 1 Diabetes Mellitus: A Systematic Review and Meta-Analysis.
    de Vries M; Westerink J; Kaasjager KHAH; de Valk HW
    J Clin Endocrinol Metab; 2020 Dec; 105(12):3842-53. PubMed ID: 32827432
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prevalence of Nonalcoholic Fatty Liver Disease in Patients With Rheumatoid Arthritis: A Systematic Review and Meta-analysis.
    Zamani M; Alizadeh-Tabari S; Chitkara P; Singh S; Loomba R
    Clin Gastroenterol Hepatol; 2023 Oct; 21(11):2789-2796. PubMed ID: 36871771
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clinical and metabolic factors associated with development and regression of nonalcoholic fatty liver disease in nonobese subjects.
    Kim NH; Kim JH; Kim YJ; Yoo HJ; Kim HY; Seo JA; Kim NH; Choi KM; Baik SH; Choi DS; Kim SG
    Liver Int; 2014 Apr; 34(4):604-11. PubMed ID: 24382309
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Serum uric acid and non-alcoholic fatty liver disease in non-obesity Chinese adults.
    Zheng X; Gong L; Luo R; Chen H; Peng B; Ren W; Wang Y
    Lipids Health Dis; 2017 Oct; 16(1):202. PubMed ID: 29037239
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cardiovascular Morbidity and Mortality Related to Non-alcoholic Fatty Liver Disease: A Systematic Review and Meta-analysis.
    Bisaccia G; Ricci F; Khanji MY; Sorella A; Melchiorre E; Iannetti G; Galanti K; Mantini C; Pizzi AD; Tana C; Renda G; Fedorowski A; De Caterina R; Gallina S
    Curr Probl Cardiol; 2023 Jun; 48(6):101643. PubMed ID: 36773944
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The epidemiology of NAFLD in Mainland China with analysis by adjusted gross regional domestic product: a meta-analysis.
    Wu Y; Zheng Q; Zou B; Yeo YH; Li X; Li J; Xie X; Feng Y; Stave CD; Zhu Q; Cheung R; Nguyen MH
    Hepatol Int; 2020 Mar; 14(2):259-269. PubMed ID: 32130675
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Nonalcoholic fatty liver disease in obese and nonobese pediatric patients.
    Kim EJ; Kim HJ
    Korean J Pediatr; 2019 Jan; 62(1):30-35. PubMed ID: 30304905
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characteristic Features of Nonalcoholic Fatty Liver Disease in Japan with a Focus on the Roles of Age, Sex and Body Mass Index.
    Tobari M; Hashimoto E
    Gut Liver; 2020 Sep; 14(5):537-545. PubMed ID: 31887811
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prevalence and Profile of Nonalcoholic Fatty Liver Disease in Lean Adults: Systematic Review and Meta-Analysis.
    Young S; Tariq R; Provenza J; Satapathy SK; Faisal K; Choudhry A; Friedman SL; Singal AK
    Hepatol Commun; 2020 Jul; 4(7):953-972. PubMed ID: 32626829
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Low serum vitamin D concentrations are associated with obese but not lean NAFLD: a cross-sectional study.
    Wang Q; Shi X; Wang J; Zhang J; Xu C
    Nutr J; 2021 Apr; 20(1):30. PubMed ID: 33794916
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Oxidized low-density lipoprotein antibodies/high-density lipoprotein cholesterol ratio is linked to advanced non-alcoholic fatty liver disease lean patients.
    Ampuero J; Ranchal I; Gallego-Durán R; Pareja MJ; Del Campo JA; Pastor-Ramírez H; Rico MC; Picón R; Pastor L; García-Monzón C; Andrade R; Romero-Gómez M
    J Gastroenterol Hepatol; 2016 Sep; 31(9):1611-8. PubMed ID: 26946071
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential Mortality Outcomes in Real-world Patients with Lean, Nonobese, and Obese Nonalcoholic Fatty Liver Disease.
    Nguyen VH; Ha A; Rouillard NA; Le RH; Fong A; Gudapati S; Park JE; Maeda M; Barnett S; Cheung R; Nguyen MH
    J Clin Transl Hepatol; 2023 Dec; 11(7):1448-1454. PubMed ID: 38161493
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prevalence of nonalcoholic fatty liver disease in patients with type 2 diabetes mellitus: A meta-analysis.
    Dai W; Ye L; Liu A; Wen SW; Deng J; Wu X; Lai Z
    Medicine (Baltimore); 2017 Sep; 96(39):e8179. PubMed ID: 28953675
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.